# CD155 Expression in Acute Myeloid Leukemia

> **NCT06369662** · — · COMPLETED · sponsor: **Assiut University** · enrollment: 93 (actual)

## Conditions studied

- Neoplasms
- Hematologic Neoplasms
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute

## Interventions

- **DIAGNOSTIC_TEST:** Flow cytometric immunophenotyping
- **DIAGNOSTIC_TEST:** Complete blood count
- **DIAGNOSTIC_TEST:** Bone marrow aspiration
- **DIAGNOSTIC_TEST:** Cytogenetic testing
- **DIAGNOSTIC_TEST:** FLT3-ITD using High resolution melting curve (HRM) analysis

## Key facts

- **NCT ID:** NCT06369662
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06369662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06369662, "CD155 Expression in Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06369662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*